EKG Labs Expands Analytical Laboratory for Medical Device and Pharmaceutical Services
St. Louis, MO – March 2, 2017 – EKG Life Science Services, LLC (EKG Labs), an analytical services laboratory supporting medical device and pharmaceutical development, announces the expansion of its analytical laboratories. Located in the Innovative Technology Enterprises (ITE) at the University of Missouri, St. Louis (UMSL), the expanded facility will include a new research laboratory and office space. The additional capacity will help to serve the growing needs of EKG Labs’ growing client base and expand the company’s service offerings in the areas of medical device and pharmaceutical analytical services. EKG took possession of the space on March 1 and will begin standard operations in the near future.
Ms. Katie Grayson, CEO of EKG Labs, welcomes the new capacity, “We are excited about the expansion and what it means for our clients. EKG Labs has been growing quickly these past few years and additional capacity means we can help our clients meet their development goals more efficiently.” Dr. Allen Kesselring, Chief Science Officer, adds, “The additional laboratory space gives us ample room to add new analytical services as well as expand our team of scientists. We are looking forward to expanding our capabilities and service offerings.”
About EKG Labs
EKG Labs is an analytical service provider for the medical device and pharmaceutical industries. Our investigational and development analytical services support the ultimate goal of regulatory filings with the FDA. Specialty analytical services include: extractables, leachables, biocompatibility, characterization, impurity identification, method development, method validation, deformulation, and other investigational activities.